Corient Capital Partners’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
Other funds holding JNJ
Corient Capital Partners's JNJ Position: Q3 2022 in Review
Corient Capital Partners held its Johnson & Johnson (JNJ) position steady in Q3 2022 at 63,040 shares worth $11.2M. The position accounts for 0.84% of the portfolio, ranked #18.
Corient Capital Partners first reported a position in JNJ in Q3 2016 and has held it in 25 quarters since. The position peaked at $19.3M in Q2 2017. 3,622 funds tracked by Wall St. Rank hold JNJ as of Q3 2022.
- Corient Capital Partners held 63,040 shares of Johnson & Johnson worth $11.2M as of Q3 2022.
- Corient Capital Partners left its Johnson & Johnson share count unchanged in Q3 2022.
- Johnson & Johnson made up 0.84% of Corient Capital Partners's portfolio in Q3 2022, its #18 holding.
- Corient Capital Partners first reported a position in Johnson & Johnson in Q3 2016 and has held it in 25 quarters since.
- Corient Capital Partners's Johnson & Johnson position peaked at $19.3M in Q2 2017.
- 3,622 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2022.
Based on Corient Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.